Lupin’s ESG score rises to 76 in S&P Global ESG Ratings November 26, 2024 Global pharma major Lupin Limited (Lupin) today announced its S&P Global ESG scores have moved up to 76 from 69 last year, well above the industry average of 30 in the pharmaceuticals sector. The company has demonstrated... Trending JP Nadda chairs meeting of Mission Steering Group (MSG) of National Health Mission Healthcare industry gives ‘Okay-Okay’ response to budget, hails research push AIIMS, RML hospital with 50 ambulances to deal with medical emergencies for G20 summit Latest Breakthrough Defence technology SSI Vimana and Project Operion launched Ayurvedic wellness brand Amma Living launched to bring traditional wisdom into everyday life Cancer Awareness, Prevention and Screening camp held at Tis Hazari Court Complex Over 90% Glaucoma cases undiagnosed in India, experts at AbbVie Conclave
